Collegium Pharmaceutical
COLL
COLL
172 hedge funds and large institutions have $734M invested in Collegium Pharmaceutical in 2022 Q1 according to their latest regulatory filings, with 29 funds opening new positions, 63 increasing their positions, 55 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
8% more funds holding
Funds holding: 159 → 172 (+13)
4.47% more ownership
Funds ownership: 103.63% → 108.09% (+4.5%)
Holders
172
Holding in Top 10
1
Calls
$719K
Puts
$497K
Top Buyers
| 1 | +$8.01M | |
| 2 | +$5.48M | |
| 3 | +$4.59M | |
| 4 |
Morgan Stanley
New York
|
+$3.5M |
| 5 |
State Street
Boston,
Massachusetts
|
+$3.36M |
Top Sellers
| 1 | -$28.9M | |
| 2 | -$5.44M | |
| 3 | -$3.01M | |
| 4 |
SDIC
South Dakota Investment Council
Sioux Falls,
South Dakota
|
-$1.53M |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$1.27M |